Updated on 17 Aug 2026, 08:06 AM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | 1,658.00 | 0.08 | 95,397.65 | 25.09 | 2.35 | 0.26 | 2.89 |
| Neuland Laboratories | 23,311.50 | 0.38 | 29,918.96 | 64.28 | 12.62 | 0.18 | 13.90 |
| Pfizer | 4,870.00 | -2.30 | 22,954.38 | 27.53 | 4.97 | 1.64 | 0.86 |
| Unichem Laboratories | 539.70 | -0.90 | 3,834.66 | 54.27 | 1.53 | - | 2.40 |
| Jagsonpal Pharmaceuticals | 225.55 | -1.74 | 1,492.96 | 34.27 | 5.43 | 1.12 | 2.39 |
| Meeting Date | Purpose |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-05-28 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results & issue of Warrants |
| 2025-11-13 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
Themis Medicare is trading at 104.70 as on Fri Aug 14 2026 10:27:11. This is 0.67% upper as compared to its previous closing price of 104.00.
The market capitalization of Themis Medicare is 964.29 Cr as on Fri Aug 14 2026 10:27:11.
The 52 wk high for Themis Medicare is 147.99 whereas the 52 wk low is 65.00
Themis Medicare can be analyzed on the following key metrics -
Themis Medicare reported a net profit of 1.14 Cr in 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.